Bocouture 100iu x 1 Vials

Mode of action:

Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine. The nerve terminals of the neuromuscular junction no longer respond to nerve impulses, and secretion of the neurotransmitter at the motor endplates is prevented. The action results in stopping the muscular contraction of the targeted muscles.

Contraindications:

-Hypersensitivity to the active substance or to any of the excipients.

-Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome).

-Infection or inflammation at the proposed injection site.